Cargando…
Macromolecular prodrugs of ribavirin: Polymer backbone defines blood safety, drug release, and efficacy of anti-inflammatory effects
Macromolecular (pro)drugs hold much promise as broad-spectrum antiviral agents as either microbicides or carriers for intracellular delivery of antiviral drugs. Intriguing opportunity exists in combining the two modes of antiviral activity in the same polymer structure such that the same polymer act...
Autores principales: | Zuwala, Kaja, Riber, Camilla F., Løvschall, Kaja Borup, Andersen, Anna H.F., Sørensen, Lise, Gajda, Paulina, Tolstrup, Martin, Zelikin, Alexander N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114659/ https://www.ncbi.nlm.nih.gov/pubmed/29432822 http://dx.doi.org/10.1016/j.jconrel.2018.02.012 |
Ejemplares similares
-
Macromolecular prodrugs of ribavirin: towards a treatment for co-infection with HIV and HCV
por: Smith, Anton A. A., et al.
Publicado: (2015) -
HIV anti-latency treatment mediated by macromolecular prodrugs of histone deacetylase inhibitor, panobinostat
por: Zuwala, Kaja, et al.
Publicado: (2016) -
Nucleic Acids as a Nature‐Inspired Scaffold for Macromolecular Prodrugs of Nucleoside Analogues
por: Krüger, Franziska, et al.
Publicado: (2019) -
Chemical Artificial Internalizing Receptors for Primary T Cells
por: Monge, Pere, et al.
Publicado: (2020) -
Synthetic Artificial Apoptosis‐Inducing Receptor for On‐Demand Deactivation of Engineered Cells
por: Monge, Pere, et al.
Publicado: (2021)